P. McCormack

发表

Miglustat

K. Goa, P. L. McCormack, P. McCormack, 2018, Reactions Weekly.

Quadrivalent Human Papillomavirus (Types 6,11,16,18) Recombinant Vaccine (Gardasil®)

E. Joura, P. L. McCormack, P. McCormack, 2010, Drugs.

Reduced-Antigen, Combined Diphtheria, Tetanus and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)

P. L. McCormack, P. McCormack, 2012, Drugs.

Pramipexole: in restless legs syndrome.

M. Siddiqui, P. McCormack, 2007, CNS drugs.

Lenalidomide: A Review of Its Continuous Use in Patients with Newly Diagnosed Multiple Myeloma Not Eligible for Stem-Cell Transplantation

P. L. McCormack, P. McCormack, 2015, Drugs & Aging.

Belimumab: A Guide to Its Use in Systemic Lupus Erythematosus

Celeste B. Burness, L. Scott, P. L. McCormack, 2012, BioDrugs.

Ultra-Short-Course Seasonal Allergy Vaccine (Pollinex® Quattro)

P. L. McCormack, A. Wagstaff, P. McCormack, 2012, Drugs.

Salmeterol/Fluticasone Propionate

G. Keating, P. L. McCormack, P. McCormack, 2012, Drugs.

Budesonide/Formoterol

K. Lyseng-Williamson, P. L. McCormack, P. McCormack, 2012, Drugs.

Olanzapine: in adolescents with schizophrenia or bipolar I disorder.

P. L. McCormack, P. McCormack, 2010, CNS drugs.

Rufinamide: a pharmacoeconomic profile of its use as adjunctive therapy in Lennox-Gastaut syndrome.

P. McCormack, 2012, PharmacoEconomics.

Etanercept: in ankylosing spondylitis.

P. L. McCormack, K. Wellington, P. McCormack, 2004, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy.

Erratum to: Eldecalcitol: a review of its use in the treatment of osteoporosis

P. L. McCormack, M. Sanford, P. McCormack, 2011, Drugs.

Nintedanib: First Global Approval

P. L. McCormack, P. McCormack, 2014, Drugs.

Dasatinib: A Guide to Its Use in Chronic Myeloid Leukemia in the EU

S. Keam, G. Keating, K. Lyseng-Williamson, 2013, BioDrugs.

Iobitridol: a review of its use as a contrast medium in diagnostic imaging.

P. L. McCormack, P. McCormack, 2013, Clinical drug investigation.

Inhaled Mometasone Furoate

G. Plosker, P. L. McCormack, P. McCormack, 2012, Drugs.

Reduced-Antigen, Combined Diphtheria, Tetanus, and Acellular Pertussis Vaccine, Adsorbed (Boostrix®)

L. Scott, P. L. McCormack, P. McCormack, 2012, BioDrugs.

Sulphydryl dependence of the inhibition of mitogen-induced human lymphocyte proliferation by sodium aurothiomalate.

D. Palmer, P. L. McCormack, P. McCormack, 1980, Biochemical Pharmacology.

Delayed-Release Multi Matrix System (MMX™) Mesalazine

C. Perry, D. M. Robinson, P. L. McCormack, 2012, Drugs.

DTaP-IPV-Hep B-Hib Vaccine (Hexaxim®)

P. L. McCormack, P. McCormack, 2013, Pediatric Drugs.

Carfilzomib: in relapsed, or relapsed and refractory, multiple myeloma.

P. L. McCormack, P. McCormack, 2012, Drugs.

Diclofenac Sodium Injection (Dyloject®)

L. Scott, P. L. McCormack, P. McCormack, 2008, Drugs.

Ibandronic Acid

G. Plosker, P. L. McCormack, P. McCormack, 2012, Drugs.

Natalizumab: a guide to its use in relapsing–remitting multiple sclerosis

G. Keating, P. L. McCormack, P. McCormack, 2014 .

Nelfinavir

M. Siddiqui, C. Perry, Risto S. Cvetković, 2012, Drugs.

Spotlight on Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) in the Prevention of Premalignant Genital Lesions, Genital Cancer, and Genital Warts in Women

E. Joura, P. L. McCormack, P. McCormack, 2011, BioDrugs.

Olmesartan medoxomil: a review of its use in the management of hypertension.

L. Scott, P. L. McCormack, P. McCormack, 2008, Drugs.

Tranexamic Acid

P. L. McCormack, P. McCormack, 2012, Drugs.

Spotlight on Olanzapine in Bipolar I Disorder

L. Wiseman, P. L. McCormack, P. McCormack, 2005, CNS drugs.

Olanzapine: a review of its use in the management of bipolar I disorder.

L. Wiseman, P. L. McCormack, P. McCormack, 2004, Drugs.